| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |